Praegnant

{ "short_title": "Praegnant", "data_mode": "900", "data_mode_number": "000001164", "official_title": "PROSPECTIVE ACADEMIC TRANSLATIONAL RESEARCH NETWORK FOR THE OPTIMIZATION OF THE ONCO\u00adLOGICAL HEALTH CARE QUALITY IN THE ADJUVANT AND ADVANCED/METASTATIC SETTING: HEALTH CARE RESEARCH, PHARMACOGENOMICS, BIOMARKERS, HEALTH ECONOMICS", "accrual_state": "running", "therapeutic_value": "nonTherapeutic", "therapieansatz_value": "not_applicable", "therapieintervention_value": "not_applicable", "therapielinie_value": "second", "ctgov_number": "NCT02338167", "eudract_number": "2014-\u00ad-000854-\u00ad-12", "general_contact_email": "studiensekretariat.gyn@ukdd.de", "general_contact_phone": "+49 351-4584202", "hauptpruefer_dd_name": "Prof. Dr. med. Pauline Wimberger", "description_laie_de": "PROSPEKTIVES AKADEMISCHES TRANSLATIONALES FORSCHUNGSNETZWERK ZUR OPTIMIERUNG DER ONKOLOGISCHEN VERSORGUNGSQUALIT\u00c4T IN DER ADJUVANTEN UND FORTGESCHRITTENEN/METASTASIERTEN SITUATION: VERSORGUNGSFORSCHUNG, PHARMAKOGENETIK, BIOMARKER, PHARMAKO\u00d6KONOMIE", "description_laie_en": "PRAEGNANT - Prospective Academic translational research network for the optimization of oncological health care quality in the advanced setting. This german study network was set up to take account of some of the recent developments in molecular medicine in the treatment of patients with metastatic breast cancer.\r\n\r\nIt is an academic registry and translational diagnostics study with the aim to build a healthcare research data base with the objective:\r\n\r\nto carry out molecular tests under study conditions\r\nto identify suitable breast cancer patients for clinical trials based on molecular testing\r\nto identify breast cancer patients suitable for clinical trials based on conventional inclusion criteria\r\nto record treatment-induced toxicities and patient\u00b4s quality of life in routine clinical practice\r\nto record, show and benchmark the reality of medical care provided to patients with advanced/metastatic breast cancer", "description_expert_de": "PROSPEKTIVES AKADEMISCHES TRANSLATIONALES FORSCHUNGSNETZWERK ZUR OPTIMIERUNG DER ONKOLOGISCHEN VERSORGUNGSQUALIT\u00c4T IN DER ADJUVANTEN UND FORTGESCHRITTENEN/METASTASIERTEN SITUATION: VERSORGUNGSFORSCHUNG, PHARMAKOGENETIK, BIOMARKER, PHARMAKO\u00d6KONOMIE", "description_expert_en": "PRAEGNANT - Prospective Academic translational research network for the optimization of oncological health care quality in the advanced setting. This german study network was set up to take account of some of the recent developments in molecular medicine in the treatment of patients with metastatic breast cancer.\r\n\r\nIt is an academic registry and translational diagnostics study with the aim to build a healthcare research data base with the objective:\r\n\r\nto carry out molecular tests under study conditions\r\nto identify suitable breast cancer patients for clinical trials based on molecular testing\r\nto identify breast cancer patients suitable for clinical trials based on conventional inclusion criteria\r\nto record treatment-induced toxicities and patient\u00b4s quality of life in routine clinical practice\r\nto record, show and benchmark the reality of medical care provided to patients with advanced/metastatic breast cancer", "rechtsgrundlage_value": "BO", "phase_amg_value": null, "main_cat_id": 3, "sub_cat_id": 16 }